|
Nov 2
|
Amgen Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
|
|
Nov 1
|
Amgen Third Quarter 2024 Earnings: EPS Beats Expectations
|
|
Nov 1
|
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
|
|
Oct 31
|
Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
|
|
Oct 31
|
Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight
|
|
Oct 31
|
Q3 2024 Amgen Inc Earnings Call
|
|
Oct 31
|
Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
|
|
Oct 31
|
Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...
|
|
Oct 31
|
Amgen (AMGN) Q3 2024 Earnings Call Transcript
|
|
Oct 30
|
Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics
|
|
Oct 30
|
Amgen (AMGN) Beats Q3 Earnings Estimates
|
|
Oct 30
|
Amgen: Q3 Earnings Snapshot
|
|
Oct 30
|
Amgen posts higher profit, obesity data on track for late this year
|
|
Oct 30
|
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
|
|
Oct 29
|
Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.
|
|
Oct 29
|
Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 79%
|
|
May 28
|
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
|
|
May 28
|
Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
|
|
May 27
|
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
|
|
May 27
|
The Biggest Biotechnology Company in Europe
|